Request Discount Coupon

View Synopsis & Table of Content
{reportSlug=global-melanoma-therapeutics-market, reportId=87563, mktKeyword=Melanoma Therapeutics, cagr=12.20, publishDate=Jun 2022, priceOption2=6800, reportTitle=Melanoma Therapeutics Comprehensive Study by Drugs (Opdivo, Yervoy, Mekinist+Tafinlar, Keytruda, Cotellic, Zelboraf, Imlygic, Generics), Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy), Stages (Stage 0 (Melanoma in Situ), Stage I, Stage II, Stage III, Stage IV), Cancer Type (Nodular Melanoma, Acral Lentiginous Melanoma, Superficial Spreading Melanoma, Others), Diagnosis (Ultrasound, Blood Tests, Dermatoscopy, CT scan, Others) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=187, priceOption1=3750, forecastYr=2027, noOfPages=241, reportKey=87122, breadcrum=Global Melanoma Therapeutics Market}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Jun 2022 241 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales